What Americans Would Pay to Lose Weight

Most people can say what they would pay for a car or a vacation, but a weight-loss medication that works is harder to price. Trimi surveyed 1,008 U.S. adults to see how they run that math, from what they would give up to afford treatment to the results that make the cost feel justified. The answers point to a country weighing a smaller body against nearly everything else in the budget, and a willingness to keep paying to hold on to the results.
Key Takeaways
- 59% of Americans would consider going into debt to afford a weight-loss medication that works.
- To afford weight-loss treatment, Americans would first cut dining out (59%), followed by subscriptions (19%) and travel (17%).
- 80% of Americans already using a GLP-1 say they would pay for weight-loss medication every month for the rest of their lives to keep the weight off, more than double the 35% of Americans overall.
- Nearly 1 in 4 Americans (24%) would pay more per month to lose 100 pounds than they would spend on a vacation.
How Far People Would Go to Access GLP-1s
Most Americans would cut something to keep weight-loss treatment in the budget, and many would be willing to go further to stay on treatment.
When Americans picture weight-loss treatment in their budget, they tend to file it alongside gym or wellness spending (31%) and health insurance (24%), not household essentials like groceries (7%) or rent (1%). People treat it as an investment in themselves, and that mindset shows up in how far they are willing to go.
More than half (59%) said they would consider going into debt to afford a weight-loss medication that works for them, especially if it helped them avoid a major health risk (41%). Women said they would pay up to $55 a month for treatment, compared with $41 among men. They are also more likely than men to go into debt to stay on treatment (62% vs. 55%).
Willingness to spend on weight loss can even outrank major purchases. Nearly 1 in 4 Americans (24%) said they would pay more per month to lose 100 pounds than they would spend on a vacation.
People are also willing to treat weight loss as a priority worth rearranging their budgets for. To free up money for treatment, Americans said they would reduce dining out first (59%), followed by subscriptions (19%) and travel (17%).
A Cost Worth It Now, and Later
Given the choice between weight-loss treatment and other things they want, nearly a third pick the treatment. And many current GLP-1 users are willing to keep paying for it for life.
When asked which outcome would make the cost of weight-loss treatments worth it, the largest share of Americans chose a clinical one, having a doctor notice a health improvement (40%). The answer shifts by generation, though. Gen Z is the most likely to want visible proof like compliments, photos, and attention while dating, with 51% naming that kind of recognition compared with 27% of baby boomers. They are also the least likely to want a doctor to notice (31%).
That payoff holds its own against major financial goals. Asked to pick just one thing for the year, Americans ranked a $5,000 raise first (25%), but reaching a goal weight or body came second (20%), ahead of an emergency fund, paying off debt, a dream vacation, or a new car. Nearly a third (30%) said they would rather spend on treatment than on something else they want, and among people already using a GLP-1, that rises to 71%.
The clearest sign of how much people value treatment is how long they are willing to pay for it. More than a third of Americans (35%) said they would pay for weight-loss medication every month for the rest of their lives if it meant keeping the weight off, and among people already using a GLP-1, that climbs to 80%.
Health First, Appearance Second
Health is what most Americans say justifies the cost of weight-loss treatment. The outcome they would pay the most for is lowering a health risk, though confidence and milestone moments also carry value.
- 55%Health reasons
- 30%Both equally
- 9%Appearance reasons
- 6%Neither
On average, Americans said they would pay the most each month to lower a health risk, at $134, followed by losing 100 pounds ($119). Nearly half (48%) said lowering a health risk is the single outcome that would justify the highest price they would be willing to pay.
A majority (55%) said the cost of weight-loss medication is easier to justify for health reasons, while 30% said health and appearance count equally and just 9% pointed to appearance alone. Younger adults are the exception. At 13%, Gen Z is the most likely generation to say the cost is easier to justify for appearance reasons.
The Bottom Line
People aren't just weighing a number on the scale. They're weighing what it would feel like to worry less about their health, to feel more like themselves, and to keep that feeling once they have it. That's worth cutting back for, and for a lot of people, it's worth borrowing for too. Once someone sees the results firsthand, paying for treatment stops feeling like a hard call. It just feels like part of taking care of themselves.
Methodology
We surveyed 1,008 Americans to explore how much they are willing to pay for weight-loss medication and how they weigh that cost against other financial priorities, such as savings, debt, and everyday spending. Respondents spanned four generations: Gen Z (21%), millennials (46%), Gen X (25%), and baby boomers (8%).
Respondents also represented a range of relationships with GLP-1 medications, including those not interested (38%), curious but not currently considering one (30%), currently using one (13%), actively considering one (12%), and those who used one in the past but stopped (8%). Data was collected in July 2026.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, adjusting, or discontinuing any medication. Individual results vary. GLP-1 medications require a prescription and should only be used under medical supervision.
About Trimi
Trimi is a U.S. telehealth provider that connects patients with licensed providers and named 503A compounding pharmacies for GLP-1 treatment, with transparent all-in pricing and no membership fees. That vantage point gives the company a close view of the cost, access, and everyday decisions behind the GLP-1 conversation. (Trimi, at trytrimi.com, is a separate company from the similarly named TrimRx.)
Fair Use Statement
Feel free to share the findings from this study for any noncommercial use. We only ask that you link back to the full study so readers can see the complete results and methodology, and please credit Trimi as the source.